Cargando…

Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors

OBJECTIVE: This study aims to explore the pathological characteristics of metabolic-related hepatocellular carcinoma (HCC) and its correlation with metabolic factors. METHODS: Fifty-one patients with liver cancer of unknown causes were enrolled. Biopsy of the liver and staining of the liver tissues...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lei, Zhao, Hong, Ding, Xiao-Yan, Yang, Kun, Wang, Gui-Shuang, Chen, Jia-Min, Han, Xiao-Yi, Wan, Gang, Zhang, Liang, Zhou, Xin-Gang, Chen, Xiang-Mei, Wang, Peng, Xie, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257051/
https://www.ncbi.nlm.nih.gov/pubmed/37304209
http://dx.doi.org/10.2147/JHC.S412129
_version_ 1785057232147185664
author Sun, Lei
Zhao, Hong
Ding, Xiao-Yan
Yang, Kun
Wang, Gui-Shuang
Chen, Jia-Min
Han, Xiao-Yi
Wan, Gang
Zhang, Liang
Zhou, Xin-Gang
Chen, Xiang-Mei
Wang, Peng
Xie, Wen
author_facet Sun, Lei
Zhao, Hong
Ding, Xiao-Yan
Yang, Kun
Wang, Gui-Shuang
Chen, Jia-Min
Han, Xiao-Yi
Wan, Gang
Zhang, Liang
Zhou, Xin-Gang
Chen, Xiang-Mei
Wang, Peng
Xie, Wen
author_sort Sun, Lei
collection PubMed
description OBJECTIVE: This study aims to explore the pathological characteristics of metabolic-related hepatocellular carcinoma (HCC) and its correlation with metabolic factors. METHODS: Fifty-one patients with liver cancer of unknown causes were enrolled. Biopsy of the liver and staining of the liver tissues with hematoxylin–eosin as well as special and immunohistochemical stains were performed. The histological subtypes of HCC were diagnosed based on the WHO Classification of Malignant Hepatocellular Tumors. The NAFLD activity score system was adopted for assessing the surrounding non-neoplastic liver tissues. RESULTS: Of the total, 42 (82.4%) patients were diagnosed with HCC, 32 had metabolic risk factors, 20 patients met the diagnostic criteria of the metabolic-associated fatty liver disease (MAFLD)-related HCC, and 40.6% (13/32) had liver cirrhosis. The incidence of cirrhosis (p = 0.033) and diabetes mellitus type 2 (p = 0.036) in patients with MAFLD-related HCC was notably higher than that in HCC patients with only metabolic risk factors. Among the 32 HCC cases with metabolic risk factors, trabecular type was the most prevalent, followed by steatohepatitis type, scirrhous type, solid type, pseudoglandular type, clear-cell type, and macrotrabecular type. The degree of tumor cells’ swelling and ballooning was found to be positively related to the degree of fibrosis in the surrounding liver tissues (p = 0.011) as well as the proportion of cirrhosis (p = 0.004). Moreover, the degree of fibrosis in the surrounding liver tissues showed a negative correlation with the levels of serum cholesterol (p = 0.002), low-density lipoprotein (p = 0.002), ApoA1 (p = 0.009), ApoB (p = 0.022), total protein (p = 0.015), WBC count (p = 0.006), and PLT count (p = 0.015). CONCLUSION: Pathological characteristics of the tumor and adjacent non-neoplastic liver tissues of HCC with metabolic risk factors were found to be correlated with metabolic abnormalities.
format Online
Article
Text
id pubmed-10257051
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102570512023-06-11 Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors Sun, Lei Zhao, Hong Ding, Xiao-Yan Yang, Kun Wang, Gui-Shuang Chen, Jia-Min Han, Xiao-Yi Wan, Gang Zhang, Liang Zhou, Xin-Gang Chen, Xiang-Mei Wang, Peng Xie, Wen J Hepatocell Carcinoma Original Research OBJECTIVE: This study aims to explore the pathological characteristics of metabolic-related hepatocellular carcinoma (HCC) and its correlation with metabolic factors. METHODS: Fifty-one patients with liver cancer of unknown causes were enrolled. Biopsy of the liver and staining of the liver tissues with hematoxylin–eosin as well as special and immunohistochemical stains were performed. The histological subtypes of HCC were diagnosed based on the WHO Classification of Malignant Hepatocellular Tumors. The NAFLD activity score system was adopted for assessing the surrounding non-neoplastic liver tissues. RESULTS: Of the total, 42 (82.4%) patients were diagnosed with HCC, 32 had metabolic risk factors, 20 patients met the diagnostic criteria of the metabolic-associated fatty liver disease (MAFLD)-related HCC, and 40.6% (13/32) had liver cirrhosis. The incidence of cirrhosis (p = 0.033) and diabetes mellitus type 2 (p = 0.036) in patients with MAFLD-related HCC was notably higher than that in HCC patients with only metabolic risk factors. Among the 32 HCC cases with metabolic risk factors, trabecular type was the most prevalent, followed by steatohepatitis type, scirrhous type, solid type, pseudoglandular type, clear-cell type, and macrotrabecular type. The degree of tumor cells’ swelling and ballooning was found to be positively related to the degree of fibrosis in the surrounding liver tissues (p = 0.011) as well as the proportion of cirrhosis (p = 0.004). Moreover, the degree of fibrosis in the surrounding liver tissues showed a negative correlation with the levels of serum cholesterol (p = 0.002), low-density lipoprotein (p = 0.002), ApoA1 (p = 0.009), ApoB (p = 0.022), total protein (p = 0.015), WBC count (p = 0.006), and PLT count (p = 0.015). CONCLUSION: Pathological characteristics of the tumor and adjacent non-neoplastic liver tissues of HCC with metabolic risk factors were found to be correlated with metabolic abnormalities. Dove 2023-06-05 /pmc/articles/PMC10257051/ /pubmed/37304209 http://dx.doi.org/10.2147/JHC.S412129 Text en © 2023 Sun et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sun, Lei
Zhao, Hong
Ding, Xiao-Yan
Yang, Kun
Wang, Gui-Shuang
Chen, Jia-Min
Han, Xiao-Yi
Wan, Gang
Zhang, Liang
Zhou, Xin-Gang
Chen, Xiang-Mei
Wang, Peng
Xie, Wen
Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
title Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
title_full Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
title_fullStr Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
title_full_unstemmed Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
title_short Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
title_sort clinicopathological features of hepatocellular carcinoma with metabolic risk factors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257051/
https://www.ncbi.nlm.nih.gov/pubmed/37304209
http://dx.doi.org/10.2147/JHC.S412129
work_keys_str_mv AT sunlei clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT zhaohong clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT dingxiaoyan clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT yangkun clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT wangguishuang clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT chenjiamin clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT hanxiaoyi clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT wangang clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT zhangliang clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT zhouxingang clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT chenxiangmei clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT wangpeng clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors
AT xiewen clinicopathologicalfeaturesofhepatocellularcarcinomawithmetabolicriskfactors